Welcome to LookChem.com Sign In|Join Free
  • or
1-Bromo-5-tert-butyl-4-methoxy-2-nitro-benzene is a chemical compound with the molecular formula C11H14BrNO3. It is a nitro compound with a bromine atom and a tert-butyl group attached to the benzene ring. The presence of a methoxy group and a nitro group on the benzene ring makes it a versatile building block for the synthesis of various organic compounds.
Used in Pharmaceutical Industry:
1-Bromo-5-tert-butyl-4-methoxy-2-nitro-benzene is used as an intermediate for the production of pharmaceuticals. Its unique structure and reactivity make it a valuable component in the synthesis of various medicinal compounds.
Used in Dye Industry:
1-Bromo-5-tert-butyl-4-methoxy-2-nitro-benzene is used as a precursor in the synthesis of dyes. Its versatile structure allows for the creation of a wide range of colorants used in various applications.
Used in Agrochemical Industry:
1-Bromo-5-tert-butyl-4-methoxy-2-nitro-benzene is used as a building block in the development of agrochemicals. Its unique properties contribute to the formulation of effective products for agricultural use.
Used in Research and Development:
1-Bromo-5-tert-butyl-4-methoxy-2-nitro-benzene is used as a precursor for synthesizing complex organic molecules in research and development. Its unique structure and reactivity make it a valuable tool for creating new compounds with potential applications in various industries.

873055-76-6

Post Buying Request

873055-76-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

873055-76-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 873055-76-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,5 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 873055-76:
(8*8)+(7*7)+(6*3)+(5*0)+(4*5)+(3*5)+(2*7)+(1*6)=186
186 % 10 = 6
So 873055-76-6 is a valid CAS Registry Number.

873055-76-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzene, 1-bromo-5-(1,1-dimethylethyl)-4-methoxy-2-nitro-

1.2 Other means of identification

Product number -
Other names 1-BROMO-5-TERT-BUTYL-4-METHOXY-2-NITRO-BENZENE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:873055-76-6 SDS

873055-76-6Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

-

Paragraph 0545, (2015/09/22)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

-

, (2012/12/14)

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

-

, (2012/04/23)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 873055-76-6